Literature DB >> 2176932

Granisetron (BRL 43694) in the treatment of cytostatic drug-induced emesis: a summary.

H Pintens1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2176932     DOI： 10.1016/0305-7372(90)90062-k

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  4 in total

Review 1.  Granisetron. A review of its pharmacological properties and therapeutic use as an antiemetic.

Authors:  G L Plosker; K L Goa
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

Review 2.  Benefits and risks of newer treatments for chemotherapy-induced and postoperative nausea and vomiting.

Authors:  Anthony L Kovac
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

3.  Adjuvant propofol enables better control of nausea and emesis secondary to chemotherapy for breast cancer.

Authors:  A Borgeat; O Wilder-Smith; M Forni; P M Suter
Journal:  Can J Anaesth       Date:  1994-11       Impact factor: 5.063

Review 4.  Volunteer models for predicting antiemetic activity of 5-HT3-receptor antagonists.

Authors:  N A Minton
Journal:  Br J Clin Pharmacol       Date:  1994-06       Impact factor: 4.335
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.